EBS Technologies has developed the NEXT WAVE™ system, a unique neurological stimulation system for the treatment of visual impairments like glaucoma and other neurological based visual impairments resulting from stroke or trauma. The system can treat the effects of these impairments and partially restore vision in many patients. The company holds several patents in the EU and the United States and has successfully demonstrated the clinical safety and efficacy of NEXT WAVE. The EBS therapy system is approved for the treatment of visual field loss in accordance with EU regulations as a medical device with a CE mark.
Investors 1
Funding Rounds 1
Mentions in press and media 2
